Listen

Description

Check out the latest QuadCast where we interview Jason Efstathiou at the 2024 ASTRO Annual Meeting about his Plenary Session on the PARTIQoL trial, which is a first of its kind randomized trial of IMRT vs. Proton Therapy for localized prostate cancer. Don't miss it.

 

@QuadShotNews

@drjefstathiou

@HarvardRadOnc

@SamuelMarcromMD

Check out the website and subscribe to the newsletter!

www.quadshotnews.com

Founders & Lead Authors: Laura Dover & Caleb Dulaney

Podcast Host: Sam Marcrom